Skip to main content
2025 Spine Summit Main banner
Spine Summit
Back

    Matthew Goodwin, MD

    Washington University School of Medicine - STL

    Matthew Lawrence Goodwin, MD
    Assistant Professor, Orthopaedic Surgery
    Assistant Professor, Neurological Surgery
    Division of Spine Surgery
    Washington University School of Medicine in St. Louis

    Dr. Goodwin's practice focuses on taking care of patients with spinal tumors, including both metastatic and primary cancers of the spine, benign-aggressive lesions of the spine, other noncancerous lesions of the spine that may require significant surgical interventions (spinal infections, radiation-induced fractures, etc)., as well as the more common degenerative or traumatic conditions of the spine.

    Dr. Goodwin has completed specialized surgical training in both neurosurgery and orthopedics, which has provided him with a unique background to treat patients with complex spinal conditions. Dr. Goodwin is dedicated to providing his patients with the highest level of care.

    Disclosure(s): AO Spine North America: Board Member/Officer/Trustee (Ongoing); Astra Zeneca, Bayer, Black Diamond, Boehringer Ingelheim, Boston Pharmaceuticals, Celularity, Chimerix, Day One Bio, Genenta, Glaxo Smith Kline, Karyopharm, Merck, Mundipharma, Novartis, Novocure, Nuvation Bio, Prelude Therapeutics, Sapience, Servi: Stock Options (Ongoing); BioNTech: Ownership Interest (Ongoing); Johnson & Johnson: Stock Options (Ongoing); KAIA: Stock Options (Ongoing); Kendall Hunt Publishing: Royalty Recipient (Ongoing); Moderna: Stock Options (Ongoing); NASS: Board Member/Officer/Trustee (Ongoing); Pfizer: Stock Options (Ongoing); ROM3: Stock Options (Ongoing)

    Presentation(s):

    Email Matthew